Despite guidelines addressing overdetection, no significant declines are seen; emphasis on active surveillance approaches is ...

Overdiagnosis of thyroid cancer in the United States remains a persistent problem, according to a study published online Feb.

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy.

In this issue of The Lancet Diabetes & Endocrinology, Michelle M Chen and colleagues1 report their findings on trends in the incidence of thyroid cancer in the USA from 1975 to 2019. The authors show ...

Despite efforts to curb overdiagnosis of thyroid cancer, the issue has continued to plague U.S. healthcare, according to results from a retrospective, population-based study.

Thyroid cancer continues to be overdiagnosed, though the survival rate remains unchanged, according to a study published Feb. 5 in The Lancet Diabetes & Endocrinology. Here are five notes from the ...

The first of such registries, dedicated to thyroid cancer, went live in March of 2024. A Breast Cancer Registry is the second ...

I wasn’t prepared for what he told me next. “You have textbook thyroid cancer and it is really far spread into your lymph nodes.” I had delayed seeing a doctor because I thought I was ...

In 2012, a routine check-up revealed a lump in her neck that turned out to be thyroid cancer. The dancer, model, and mom of four encouraged people to seek routine preventive care. "I took that ...

While doctors haven’t pinpointed exact causes, certain factors significantly increase your chances of developing thyroid cancer. Women face three times higher risk than men, particularly between ...